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ABSTRACT : The early postoperative results of pancreatoduodenectomy performed 
in our institute during the last 20 years were reviewed, dividing the cases into two groups, 
from 1970 to 1979 and from 1980 to 1989. 
 Among a total of 136 pancreatoduodenctomies, 52 were performed in the earlier decade 
and 84 in the latter decade. Patients were significantly older in the latter than in the earlier 
decade. In the earlier decade, postoperative complications developed in 28.8% of the 
patients with a 19.2% overall mortality rate. In the latter decade, the complications occurred 
in 27.4% with a 6.0% mortality rate. There was a significant decrease in overall mortality 
rate between the two decades. The most common complication was the dehiscence of 
pancreatojejunostmy, but life-threatening major leakage was decreased. It was considered 
that recent improvements in surgical techniques and intraoperative and perioperative 
management contributed to the improvement of the results of this procedure. However, 
continuing efforts are needed to reduce the morbidity rate, which remains high.
       INTRODUCTION 
 Pancreatoduodenectomy is accepted as a 
standard operation for malignant lesions in the 
area of the head of the pancreas. The main 
disadvantage of this procedure is said to be a 
high postoperative mortality and morbidity rate 
due to the fact that it is one of the most intricate 
and difficult procedures in surgery of the gastro-
intestinal tracts 3>. It has been reported, 
however, that recent improvements in surgical
techiques and intraoperative and perioperative 
management have reduced the risk of failure 
of pancreatoduodenectomy4-6). To confirm this 
trend in our series, the early postoperative 
results of pancreatoduodenectomy performed in 
our institute during the last 20 years were 
reviewed.
   PATIENTS AND METHODS 
 Between January 1970 and December 1989, 136 
patients underwent pancreatoduodenectomy at
Fig. 1. Our method of reconstruction after pan-
       creatoduodenectomy. Note the P-loop 
     jejunal limb.
Fig. 2 b. Pancreatojejunostomy in the latter 
      decade. When the duct is dilated, duct-
       to-jejunal mucosa anastomosis is per-
      formed.
Fig. 2 a. Pancreatojejunostomy in the earlier 
      decade. Note that the cut stump of the 
      pancreas is invaginated into the jejunal
      lumen, and that the decompression tube 
       does not have a knot.
Fig. 2 c. Pancreatojejunostomy in the latter 
      decade. When the duct is normal in size, 
       duct-to-jejunal anastomosis is not per-
       formed. Note the presence of a knot and
      holes on the decompression tube.
the Second Department of Surgery, Nagasaki 
University School of Medicine. The mean age 
was 61.5 years, ranging from 30 to 84. There 
were 81 males and 55 females. The patients were 
divided into two groups on the basis of decades, 
that is, from 1970 to 1979 and from 1980 to 1989, 
to elucidate the trends in mortality and mor-
bidity rate after operation. In each group, age, 
surgical indications, postoperative compli-
cations, mortality rate in hospital, 30-day 
mortality rate, treatment of the complications 
and preoperative laboratory data were analyzed. 
 Our standard method of pancreato-
duodenectomy was described elsewhere''8). 
Briefly, the resection is done in the usual manner 
and the reconstruction is a modification of 
Child's method as shown in Figure 1. New 
methods of anastomosis between the remaining 
pancreas and the jejunm were done in the latter 
decade. One was a change in the anastomotic 
procedure itself and the other a change in the 
decompression tube.' In the earlier decade, the 
whole cut stump of the remaining pancreas was 
invaginated in the jejunal lumen (Fig. 2a), but 
in the latter decade, the duct-to-jejunal mucosa 
anastomosis was employed (Fig. 2b). A silastic 
plastic catheter without a knot was used for de-
compression of the remaining pancreatic duct 
in the earlier decade (Fig. 2a), while in the latter 
decade a knot was made 5cm from the tip of 
the catheter to prevent the tube from sliding out 
of the pancreatic duct (Fig. 2b). When the 
duct-to-jejunal mucosa anastomosis was ruled 
out, the tube was simply ligated with the
'pancreatic duct using absorbable purse -string 
suture (Fig. 2c). There were no holes in the 
catheter on the jejunal side of the knot. In these 
cases, pancreatic juice was drained totally to the 
outside of the body. Eighty patients with 
obstructive jaundice, that is, those in whom total 
bilirubin was more than 10mg/dl, underwent 
preoperative biliary drainage. Chi-squared test 
and Student t-test were used for statistical 
analysis of the data.
          RESULTS 
 The 52 patients undergoing surgery in the 
earlier decade had a mean age of 57.6 years, 
while the 84 patients in the latter decade had 
a mean age of 64.1. The patients in the latter 
were significantly older than those in the earlier 
decade (p<0.01). 
 The indications for pancreatoduodenectomy 
are summarized in Table 1 for each decade. The 
total number of patients in the latter decade was 
higher because the resection of bile duct car-
cinoma and pancreatic carcinoma increased. 
 Postoperative complications developend in 38 
of 136 patients (27.9%) during the 20 year period 
(Fig. 3). Fifteen patients died in hospital after 
operation, and the overall mortality rate was 
11.0%. Nine of these patients died within 30 days 
after surgery, showing a 30-day mortality rate 
of 6.6%. In the earlier decade, postoperative 
complications developed in 15 patients (28.8%). 
The overall mortality rate was 19.2% (10 patients) 
and the 30-day mortality rate was 11.5%. In the
  Table 1. Indications for pancreatoduodenectomy in the 136 patients 
                            Number of Patients 
     Diagnosis Total 1970-1979 1980-1989 Total 
                     (n=136) (n=52) (n=84) 
Carcinoma of the : 
  Bile duct 40 14 26 
  Ampulla 36 22 14 
   Pancreas 33 7 26 
   Stomach 5 2 3 
   Duodenum 4 2 2 
  Gallbladder 3 0 3 
  Colon 1 0 1 122 
Chronic pancreatitis 9 4 5 
Benign duodenal tumor 2 0 2 
Others 3 1 2 14
latter decade, complications occurred in 23 
patients (27.4%) and 5 of whom died, indicating 
an overall mortality rate and 30-day mortality 
rate of 6.0% 3.6%, respectively. There was a 
significant decrease in overall mortality rate 
from the earlier to the latter decade (P<0.02). 
 Table 2 shows the incidence and overall 
mortality rate by each complication. The most 
common complication in both decades was 
dehiscence of pancreatojejunostomy. The inci-
dence did not change from the earlier to the 
latter decade. However, major leakage, which 
often causes a fatal outcome, decreased from 
50% to 17%, although the decrease was not 
statistically significant. Other major life-
threatening complications were bile leakage and 
liver failure. 
 The dehiscence of pancreatojejunostomy was 
also analyzed according to disease (Table 3). 
Patients with carcinoma of the head of the 
pancreas showed a lower incidence of dehis-
cence of pancreatojejunostomy than patients 
with carcinoma of other sites or benign disease. 
 Management and prognosis of patients with 
dehiscence of pancreatojejunostomy is shown 
in Figure 4. All 5 patients who developed major 
leakage of pancreatic juice died due to gastro-
intestinal and/or intra-abdominal bleeding, 
followed by multiple organ failures. All except
one of 13 patients with minor leakage were cured 
by conservative treatment only. The conserva-
tive treatment during the last 7 years included 
nutritional support by means of total parenteral 
nutrition and H2-blocker for gastrointestinal 
bleeding. In the earlier decade, total parenteral 
nutrition was not employed extensively and 
H2-blocker was not used at all.
Fig. 3. Morbidity, overall mortality and 30-day 
      mortality rates in the total period and each 
      decade. ® Morbidity rate, C] overall 
      mortality rate and 0 30-day mortality 
         rate
( ) : Number of patients, GI bleeding : Gastrointestitinal bleeding, Intra- abd.: Intra-abdominal, Reop : 
Reopration, TPN : Total parenteral nutrition.
Fig. 4. Management and prognosis in the event of dehiscence of pancreatojejunostomy.
           Table 2. Various postoperative complications and respective mortality rates 
                                  Number of patients (%) Mortality rate % ( )
                              total 1970-1979 1980-1989 1970-1979 1980-1989                              (
n=136) (n=52) (n=84) 
Dehiscence of pancreatojejunostomy 18 (13.2) 6(11.5) 12 (14.3) 50 [3/6) 17 [2/12) 
       major leakage 5 3 2 100 [3/3) 100 [2/2) 
       minor leakage 13 3 10 0 [0/3) 0 [0/10) 
Dehiscence of CJS 4(2.9) 2(3.8) 2(2.4) 100 [2/2) 0 [0/2) 
Liver failure 3(2.2) 2(3.8) 1(1.2) 100 [2/2) 100 [1/1) 
GI bleeding 2(1.5) 1(1.9) 1(1.2) 100 [1/1) 0 (0/1) 
Intra-abdominal abscess 2(1.5) 1(1.9) 1(l.2) 0 [0/1) 0 [0/1) 
Pneumonia 2(l.5) 1(1.9) l (I.2) 0 [0/1) 100 [1/1) 
Intra-abdominal bleeding 1(0.7) 0(0) 1(1.2) 0 (0/0) 0 (0/1) 
Others 6(4.4) 2(3.8) 4(4.8) 100 [2/2) 25 [0/4) 
    Total 38 (27.9) 15 (28.8) 23 (27.4) 
                 n : number of patients [ ) : number of patients
                GI bleeding : Gastrointestinal bleeding 
               CJS : Cholagiojejunostomy
 Table 3. Incidence of dehiscence of pancreatojejunostomy and mortality rate according to disease 
                                  No. of Cases with Dehiscence Mortality rate
         Diagnosis Total 1970-1979 1980-1989 Incidence (%) 
                             (n=136) (n=52) (n=84) 
Carcinoma of the : 
    Head of the pancreas 2/33 0/7 2/26 6.1% 0(0) 
    Ampulla of Vater 5/36 3/22 2/14 13.9% 2(5.6) 
    Terminal common bile duct 7/40 1/14 6/26 17.5% 2(5.0) 
    Other sites 2/13 1/4 1/9 15.4% 1(7.7) 
Chronic pancreatitis 1/9 1/4 0/5 11.1% 0(0) 
Other benign diseases 1/5 0/1 1/4 20.0% 0(0)
 Preoperative laboratory data such as red 
blood cell count, serum total protein, albumin, 
total bilirubin, choline esterase, SGOT and total 
cholesterol are shown in Table 4 for the patients 
with and without complications. There was no 
significant differences in any of the data.
     Table 4. Preoperative laboratory data 
    Items Complications (-) Complications (+)                 (N =98) (N =38) 
RBC (x 10p1) 370 ±69 409 ± 42 
TP (g/dl) 6.8 ± 0.7 6.9 ± 0.7 
Alb.(g/dl) 3.5 ± 0.6 4.0 ± 0.5 
T. Bil (mg/dl) 7.5 ± 6.4 7.1 ± 7.2 
Ch-E (ApH/h) 0.61± 0.14 0.64± 0.28 
SGOT (IU/L) 55.6 ±35.8 66.2 ± 33.8 
T. Chol. (mg/dl) 203.7 ±75.8 191.5 ±104.0
                             (mean ± SD) 
N : Number of patients, Alb.: Albumin, T. Bil : Total 
bilirubin, Ch-E : Choline esterase, T. Chol : Total 
cholesterol
         DISCUSSION 
 The patients undergoing pancreatoduode-
nectomy were significantly older in the latter 
decade than in the earlier decade in our 
department. Moreover, in the latter decade, 
resection was performed on patients with more 
advanced stages of the carcinoma of the head 
of the pancreas, which had been considered 
unresectable in the earlier decade. 
 The present study, however, revealed a 
significant reduction in overall mortality rate 
from the earlier to the latter decade. We 
confirmed that pancreatoduodenectomy can be 
performed with a postoperative mortality rate 
of approximately 6%, similar to that reported 
in other series9-12) 
 The morbidity rate still remains high. The 
main postoperative complication was dehis-
cence of pancreatojejunostmy, which occasio-
nally resulted in death due to intra-abdominal 
hemorrhage or abscess followed by multiple 
organ failures. The frequency of dehiscence 
with major leakage of pancreatic juice, however, 
decreased in the latter decade. The decrease 
was not statistically significant because of the 
small number of patients suffering dehiscence 
of pancreatojejunostmy. The decrease of major 
leakage was accomplished by performing a 
duct-to-jejunal mucosa anstomosis between the 
remaining pancreas and jejunum"), and by 
using a different kind of decompression tube 
in the pancreatic duct. Duct-to-jejunal mucosa 
anastomosis is easier in patients with carcinoma 
of the head of the pancreas than in patients with 
a normal pancreas, because the pancreas is 
hardened and the duct is dilated. This could 
account for the fact that the incidence of 
dehiscence of pancreatojejunostomy was lower 
in patients with carcinoma of the head of the 
pancreas than in patients with carcinoma of 
other sites. In patients with a normal-sized 
pancreatic duct, duct-to-jejunal mucosa anas-
tomosis is difficult. It is sufficient to insert a 
purse-string sutured decompression tube into 
the jejunal lumen with addition of anastmosis 
between the pancreatic parenchyma and 
seromuscular layer of the jejunum. There are 
no holes in the catheter on the jejunal side, 
resulting in total drainage of pancreatic juice 
outside the body in these cases. 
 Total parenteral nutrition (TPN) was used 
extensively in the postoperartive management 
of the patients in the latter decade. TPN 
enhances the nutritional condition of the 
patients, contributing to anastomotic healing. 
Morever, TPN cured minor leakage from the 
pancreatojejunostomy in conjunction with ade-
quate drainage of the abdominal cavity in 
almost all patients. The drains inserted at the 
time of operation were used when anastomotic 
leakage occurred. A silastic or Penrose drain 
should be inserted with great care close to each 
anastomotic site. 
 Continuing efforts are needed to improve the 
surgical results of pancreatoduodenectomy, 
especially to reduce the high morbidity rate.
          REFERENCES 
1) Newton WT: Mortality and morbidity associ-
   ated with resection of pancreatoduodenal can-
   cer. Ann. Surg., 27;74, 1961. 
2) Morris PJ and Nardi GI: Pancreaticoduodenal 
   cancer. Arch. Surg., 92;834, 1966. 
3) Smith PE, Kremenz ET, Read RJ and Bufkind 
   WJ : An analysis of 600 patients with carcinoma 
   of pancreas. Surg. Gynecol. Obstet., 124; 1288, 
  1967. 
4) Grace PA, Pitt HA, Tompkins RK, DenBesten 
   L and Longmire WP: Decreased morbidity and 
   mortality after pancreatoduodenectomy. Am. J. 
   Surg., 151 ; 141, 1986. 
5) Crist DW, Sitzmann JV and Camereron JL : 
   Improved hospital morbidity, mortality, and 
   survival after the Whipple procedure. Ann. 
   Surg., 206; 358, 1987. 
6) Araida T, Hanyu F, Imaizumi T, Nakamura M, 
  Yoshikawa T, Suzuki M and Miura 0: The 
   study on early complications in 500 patients with 
   pancreatoduodenectomy. Suizo 3 ; 27, 1988 (in 
  Japanese). 
7) Tsuchiya R, Furukawa M, Furuse H, Sugihara 
  Y, Oshibuchi H, Noritomi S and Nakashima Y: 
   Pancreatoduodenectomy ; Our experiences and 
   method of reconstruction. Jpn. J. Surg., 1 ; 167, 
  1971. 
8) Yoshino R and Tsuchiya R : Indication and 
   standard operative method of pancreatico-
   duodenectomy. Gastroenterological Surgery 10; 
  289, 1987 in Japanese. 
9) Montagne GJ, Lygidakis NJ, Heyde MN and 
   Leeuwen DJ: Early postoperative complications 
  after (Sub)total pancreatoduodectomy ; the AMC 
   experience. Hepato gastroenterol., 35; 226, 1988. 
10) Trede M and Schwall G : The complications of 
   pancreatectomy. Ann Surg., 207; 39, 1988. 
11) O'Brien PH and Mincey KH : Analysis of 
   pancreatoduodenectomy. J. Surg. Oncol., 28; 50, 
  1985. 
12) Funovics JM, Zoch G, Wenzl E and Schulz F : 
   Progress in reconstruction after resection of the
   head of the pancreas. Surg. Gynecol. Obstet., 164; 
  545, 1987.
